Toggle navigation
Home
About
Company
Our Team
R&D
Technology
Projects
Publications
Our expertise
News
Contact
News
Labelised Deeptech by BPI France
Tuesday, March 15th 2022
Vaxinano is delighted to have successfully obtained the Deeptech label from the BPI (Public Investment Bank)
This grant will allow us to scale up our toxoplasmosis vaccine
< Back